V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160012980 | 160006288 | 1.75 | 83.2 | Palliative (P) | 2018-02-04 | 2018-02-04 | Doxorubicin + Ifosfamide | 01 | Y | CISPLATIN + PACLITAXEL | 100985543 |
| 160012982 | 160006289 | 1.84 | 67 | Disease modification (D) | null | 2018-12-17 | EW EuroEwing 2012 Arm B VDC | 02 | Y | BENDAMUSTINE + RITUXIMAB | 100417915 |
| 160012988 | 160006291 | 1.82 | 83.4 | Palliative (P) | 2017-05-08 | 2017-05-08 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 100063833 |
| 160012989 | 160006292 | 1.7 | 63.3 | Palliative (P) | 2017-12-28 | 2017-12-28 | CONFIRM TRIAL | 02 | N | DOXORUBICIN | 101042140 |
| 160012990 | 160006293 | 1.82 | 65 | Curative (C) | 2018-05-25 | 2018-06-02 | STS Rhabdomyosarco RMS 2005 IVADoVV | 02 | N | DOXORUBICIN | 101375745 |
| 160012991 | 160006294 | 1.75 | 79.5 | Palliative (P) | 2017-03-29 | 2017-04-03 | VIDE | 02 | N | DOXORUBICIN | 100482066 |
| 160012992 | 160006295 | 1.54 | 86.1 | Palliative (P) | 2017-03-09 | 2017-04-07 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101354948 |
| 160012993 | 160006296 | 1.59 | 82.3 | Palliative (P) | 2019-09-11 | 2019-10-06 | Imatinib 400mg | 02 | N | ETOPOSIDE + IFOSFAMIDE | 101816331 |
| 160012994 | 160006297 | 1.75 | 72.5 | null | null | 2017-12-26 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 100710017 |
| 160012995 | 160006298 | 1.68 | 111 | Neo-adjuvant (N) | 2018-07-20 | 2018-07-28 | DOXORUBICIN | 02 | N | LIPOSOMAL DOXORUBICIN | 100907122 |
| 160012999 | 160006299 | 1.77 | 87.6 | Palliative (P) | 2018-04-24 | 2018-05-10 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100215334 |
| 160013000 | 160006300 | 1.62 | 82.8 | Palliative (P) | 2018-10-31 | 2018-11-03 | IVADo | N | N | DOXORUBICIN | 100624951 |
| 160013002 | 160006301 | 1.73 | 72.6 | Palliative (P) | 2018-04-06 | 2018-04-17 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101135082 |
| 160013003 | 160006302 | 1.71 | 72.4 | Palliative (P) | 2018-05-03 | 2018-05-29 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100024178 |
| 160013004 | 160006303 | 1.54 | 62.4 | Palliative (P) | 2017-11-22 | 2017-11-30 | Bevacizumab 15mg/kg | 02 | null | LIPOSOMAL DOXORUBICIN | 101351226 |
| 160013007 | 160006304 | 1.83 | 87 | Palliative (P) | 2019-08-07 | 2019-08-08 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100852856 |
| 160013008 | 160006305 | 0 | 60.7 | Curative (C) | 2019-11-27 | 2019-12-13 | CYCLOPHOSPHAMIDE | 02 | N | PACLITAXEL | 100120405 |
| 160013009 | 160006306 | 1.62 | 121.4 | 02 | 2019-06-18 | 2019-06-18 | Cisplatin + Pemetrexed | 02 | Y | CISPLATIN + PEMETREXED | 101850687 |
| 160013010 | 160006307 | 1.68 | 85 | Curative (C) | 2016-06-26 | 2016-06-29 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 101464775 |
| 160013012 | 160006308 | 1.74 | 71.7 | Curative (C) | 2016-08-11 | 2016-08-17 | Bevacizumab 7.5mg/kg | 02 | N | DOXORUBICIN + OLARATUMAB | 101255066 |
| 160013014 | 160006309 | 1.78 | 78.35 | Palliative (P) | 2017-05-18 | 2017-05-23 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 100398207 |
| 160013015 | 160006310 | 1.73 | 90.4 | Palliative (P) | 2018-05-05 | 2018-05-07 | Cisplatin + Pemetrexed | 2 | N | CISPLATIN + PEMETREXED | 101477384 |
| 160013019 | 160006311 | 1.79 | 81.6 | Curative (C) | 2018-12-05 | 2018-12-12 | Trial Unspecified | N | N | TRIAL | 101190060 |
| 160013022 | 160006312 | 1.78 | 78.35 | Palliative (P) | 2018-10-01 | 2018-10-12 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 100821906 |
| 160013023 | 160006313 | 1.74 | 69.5 | Curative (C) | 2016-05-25 | 2016-05-30 | NB HRNBL-1 COJEC Ind COURSE A | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + OBINUTUZUMAB + VINCRISTINE | 100256736 |
| 160013026 | 160006314 | 1.73 | 77.7 | Curative (C) | 2016-07-13 | 2016-07-14 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 100784534 |
| 160013027 | 160006315 | 1.71 | 77.4 | Palliative (P) | 2018-10-28 | 2018-11-20 | Paclitaxel 80mg/m2 day 1 8 15 | 2 | N | DOXORUBICIN + OLARATUMAB | 101066799 |
| 160013031 | 160006316 | 1.82 | 74 | Palliative (P) | 2019-12-01 | 2019-12-01 | Doxorubicin + Ifosfamide | 02 | N | EW EUROEWING 2012 ARM B VDC | 101708657 |
| 160013037 | 160006317 | 1.68 | 78.6 | Palliative (P) | 2016-03-14 | 2016-03-16 | VINORELBINE | 02 | 2 | DOXORUBICIN | 100534025 |
| 160013038 | 160006318 | 1.47 | 95.9 | Palliative (P) | 2018-11-20 | 2018-12-09 | Doxorubicin 75mg/m2 | 02 | N | DOXORUBICIN | 101790813 |
| 160013039 | 160006319 | 1.69 | 71.8 | Palliative (P) | 2016-03-16 | 2016-04-04 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | NB HRNBL-1 COJEC IND COURSE A | 101266644 |
| 160013040 | 160006320 | 1.71 | 95 | Palliative (P) | 2021-10-11 | 2021-10-11 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100945144 |
| 160013043 | 160006321 | 1.8 | 84.6 | Palliative (P) | 2018-09-23 | 2018-10-01 | Cisplatin + Pemetrexed | null | N | CISPLATIN + PEMETREXED | 100443876 |
| 160013044 | 160006322 | 1.78 | 77.5 | Palliative (P) | null | 2017-12-21 | Doxorubicin 75mg/m2 | n | N | CISPLATIN + DOXORUBICIN | 100513918 |
| 160013046 | 160006323 | 1.83 | 87.7 | Curative (C) | 2019-07-15 | 2019-08-03 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100261841 |
| 160013048 | 160006324 | 1.61 | 74.9 | Neo-adjuvant (N) | 2019-04-16 | 2019-04-17 | DOXORUBICIN | N | N | DOCETAXEL + GEMCITABINE | 100308603 |
| 160013049 | 160006325 | 1.63 | 68.4 | Neo-adjuvant (N) | 2018-04-30 | 2018-04-30 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100147114 |
| 160013052 | 160006326 | 1.62 | 81 | Palliative (P) | 2016-05-31 | 2016-06-18 | Doxorubicin + Olaratumab | 02 | N | DOXORUBICIN | 101496545 |
| 160013054 | 160006327 | 1.88 | 85 | Palliative (P) | 2016-07-05 | 2016-07-09 | Imatinib 400mg | 02 | N | DOCETAXEL + GEMCITABINE | 100292304 |
| 160013058 | 160006328 | 1.69 | 87.7 | Palliative (P) | 2018-10-17 | 2018-10-17 | Trabectedin | 02 | N | LIPOSOMAL DOXORUBICIN | 100218887 |
| 160013059 | 160006329 | 1.84 | 59.4 | Palliative (P) | 2019-01-09 | 2019-01-24 | Abiraterone | N | N | VINORELBINE | 101188914 |
| 160013060 | 160006330 | null | 80.2 | Neo-adjuvant (N) | 2017-06-07 | 2017-06-09 | Trial Unspecified | 02 | N | DOXORUBICIN + OLARATUMAB | 100263337 |
| 160013061 | 160006331 | 1.61 | 82.9 | null | 2020-09-22 | 2020-10-16 | OCTREOTIDE | 02 | N | TRIAL UNSPECIFIED | 101356523 |
| 160013063 | 160006332 | 1.85 | 61.4 | Neo-adjuvant (N) | 2018-04-25 | 2018-05-02 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100049338 |
| 160013066 | 160006333 | 1.76 | 75.2 | Neo-adjuvant (N) | 2018-01-01 | 2018-01-15 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101369235 |
| 160013068 | 160006334 | 1.7 | 134 | null | 2019-12-08 | 2019-12-30 | DOXORUBICIN | 02 | null | ATOMIC-MESO TRIAL | 101444078 |
| 160013069 | 160006335 | 1.62 | 85.4 | null | 2018-04-05 | 2018-04-25 | DACTINOMYCIN + IFOSFAMIDE + MESNA + VINCRISTINE | 02 | null | IPILIMUMAB + NIVOLUMAB | 100718754 |
| 160013070 | 160006336 | 1.78 | 7.9 | Palliative (P) | 2017-05-23 | 2017-05-29 | Cisplatin + Pemetrexed | 01 | N | CISPLATIN + PEMETREXED | 100121825 |
| 160013071 | 160006337 | 1.71 | 60.8 | Palliative (P) | 2019-03-22 | 2019-03-22 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 101799854 |
| 160013074 | 160006338 | 1.73 | 93.1 | Curative (C) | 2016-12-31 | 2017-01-05 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101813506 |